Entera Bio Stock Buy Hold or Sell Recommendation
| ENTX Stock | USD 1.88 0.03 1.62% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Entera Bio is 'Strong Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Entera Bio given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Entera Bio, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Entera Bio Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Entera Stock please use our How to Invest in Entera Bio guide. In addition, we conduct extensive research on individual companies such as Entera and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Entera Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Entera |
Execute Entera Bio Buy or Sell Advice
The Entera recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Entera Bio. Macroaxis does not own or have any residual interests in Entera Bio or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Entera Bio's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Risky | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Investor Sentiment | Excited | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Entera Bio Trading Alerts and Improvement Suggestions
| Entera Bio generated a negative expected return over the last 90 days | |
| Entera Bio has high historical volatility and very poor performance | |
| Entera Bio may become a speculative penny stock | |
| The company reported the previous year's revenue of 14 K. Net Loss for the year was (8.89 M) with profit before overhead, payroll, taxes, and interest of 9 K. | |
| Entera Bio currently holds about 17.28 M in cash with (7.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.6. | |
| Entera Bio has a poor financial position based on the latest SEC disclosures | |
| Roughly 19.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Entera Bio Ltd expected to post a loss of 8 cents a share - Earnings Preview - TradingView |
Entera Bio Returns Distribution Density
The distribution of Entera Bio's historical returns is an attempt to chart the uncertainty of Entera Bio's future price movements. The chart of the probability distribution of Entera Bio daily returns describes the distribution of returns around its average expected value. We use Entera Bio price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Entera Bio returns is essential to provide solid investment advice for Entera Bio.
| Mean Return | 0.02 | Value At Risk | -6.01 | Potential Upside | 10.05 | Standard Deviation | 5.04 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Entera Bio historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Entera Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as Entera Bio, soars without any apparent reason? This usually happens because many institutional investors are aggressively trading Entera Bio back and forth among themselves.
| Shares | Group One Trading, Lp | 2024-12-31 | 51.0 |
Entera Bio Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Investments | (86K) | (17K) | (102K) | (15K) | (17.3K) | (18.1K) | |
| Change In Cash | (6.6M) | 16.3M | (12.6M) | (1.3M) | (1.2M) | (1.1M) | |
| Free Cash Flow | (10.5M) | (9.1M) | (12.5M) | (7.3M) | (6.6M) | (6.9M) | |
| Depreciation | 225K | 53K | 64K | 56K | 64.4K | 97.3K | |
| Other Non Cash Items | (1.2M) | 18K | (78K) | 1.5M | 1.7M | 1.8M | |
| Capital Expenditures | 40K | 53K | 17K | 47K | 15.3K | 14.5K | |
| Net Income | (10.0M) | (12.2M) | (13.1M) | (8.9M) | (8.0M) | (8.4M) | |
| End Period Cash Flow | 8.6M | 25.0M | 12.4M | 11.1M | 12.7M | 11.8M | |
| Change To Netincome | 783K | (314K) | 1.7M | 2.3M | 2.7M | 2.8M |
Entera Bio Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Entera Bio or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Entera Bio's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Entera stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0 | |
β | Beta against Dow Jones | -0.06 | |
σ | Overall volatility | 5.02 | |
Ir | Information ratio | 0.02 |
Entera Bio Volatility Alert
Entera Bio shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Entera Bio's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Entera Bio's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Entera Bio Fundamentals Vs Peers
Comparing Entera Bio's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Entera Bio's direct or indirect competition across all of the common fundamentals between Entera Bio and the related equities. This way, we can detect undervalued stocks with similar characteristics as Entera Bio or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Entera Bio's fundamental indicators could also be used in its relative valuation, which is a method of valuing Entera Bio by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Entera Bio to competition |
| Fundamentals | Entera Bio | Peer Average |
| Return On Equity | -1.45 | -0.31 |
| Return On Asset | -0.71 | -0.14 |
| Operating Margin | (71.93) % | (5.51) % |
| Current Valuation | 62.64 M | 16.62 B |
| Shares Outstanding | 36.83 M | 571.82 M |
| Shares Owned By Insiders | 19.12 % | 10.09 % |
| Shares Owned By Institutions | 27.72 % | 39.21 % |
| Number Of Shares Shorted | 104.48 K | 4.71 M |
| Price To Earning | 2.10 X | 28.72 X |
| Price To Book | 10.73 X | 9.51 X |
| Price To Sales | 699.44 X | 11.42 X |
| Revenue | 14 K | 9.43 B |
| Gross Profit | 9 K | 27.38 B |
| EBITDA | (8.8 M) | 3.9 B |
| Net Income | (8.89 M) | 570.98 M |
| Cash And Equivalents | 17.28 M | 2.7 B |
| Cash Per Share | 0.60 X | 5.01 X |
| Total Debt | 390 K | 5.32 B |
| Debt To Equity | 0.01 % | 48.70 % |
| Current Ratio | 10.89 X | 2.16 X |
| Book Value Per Share | 0.18 X | 1.93 K |
| Cash Flow From Operations | (7.31 M) | 971.22 M |
| Short Ratio | 1.45 X | 4.00 X |
| Earnings Per Share | (0.26) X | 3.12 X |
| Target Price | 10.0 | |
| Number Of Employees | 18 | 18.84 K |
| Beta | 1.63 | -0.15 |
| Market Capitalization | 69.24 M | 19.03 B |
| Total Asset | 11.77 M | 29.47 B |
| Retained Earnings | (104.39 M) | 9.33 B |
| Working Capital | 10.17 M | 1.48 B |
| Current Asset | 8.46 M | 9.34 B |
| Current Liabilities | 7.64 M | 7.9 B |
Note: Acquisition by Ellis Sean of 40000 shares of Entera Bio at 0.6 subject to Rule 16b-3 [view details]
Entera Bio Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Entera . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Entera Bio Buy or Sell Advice
When is the right time to buy or sell Entera Bio? Buying financial instruments such as Entera Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Entera Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Alternative Currency ETFs Thematic Idea Now
Alternative Currency ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Alternative Currency ETFs theme has 55 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Alternative Currency ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Entera Stock Analysis
When running Entera Bio's price analysis, check to measure Entera Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entera Bio is operating at the current time. Most of Entera Bio's value examination focuses on studying past and present price action to predict the probability of Entera Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entera Bio's price. Additionally, you may evaluate how the addition of Entera Bio to your portfolios can decrease your overall portfolio volatility.